[1. Badalian-Very G, Vergilio JA, Degar BA, Rodriguez-Galindo C, Rollins BJ. Recent advances in the understanding of Langerhans cell histiocytosis. Br J Haematol. 2012; 156(1): 163-72.10.1111/j.1365-2141.2011.08915.x22017623]Search in Google Scholar
[2. Hand A. General tuberculosis. Trans Pathol Soc Philadelphia. 1883;16:282.]Search in Google Scholar
[3. Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LjM, Arico M et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med PediatrOncol. 1997;29(3): 157-66.]Search in Google Scholar
[4. Writing Group of the Histiocyte Society. Histiocytosis syndromes in children. Lancet. 1987;1:208-9.]Search in Google Scholar
[5. Oreshkov K Stoeva N. [How far we have come in understanding Langerhans histiocytosis]. Medinfo. 2008; 12:35-40. Bulgarian.]Search in Google Scholar
[6. Lynch JP. Rare interstitial lung diseases: pulmonary Langerhans cell histiocytosis, lymphangioleiomyomatosis, and cryptogenic organizing pneumonia. In: ACCP Pulmonary Medicine Board Review. 25th ed. Northbrook, IL: American College of Chest Physicians; 2009.10.1378/pmbr.25th.585]Search in Google Scholar
[7. Kissenpfennig A, A'l't-Yahia S, Clair-Moninot V, Stossel H, Badell E, Bordat Y, et al. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol. 2005;25(l):88-99.10.1128/MCB.25.1.88-99.200553879115601833]Search in Google Scholar
[8. Shortman K, Naik SH. Steady-state and inflammatory dendritic-cell development. Nat Rev Immunol. 2007;7:19-30.10.1038/nri199617170756]Search in Google Scholar
[9. Berres ML, Merad M, Allen CE. Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? Br J Haematol. 2015; 169(1):3-13.10.1111/bjh.13247519322125430560]Search in Google Scholar
[10. Csire M, Mikala G, Jako J, Masszi T, Janosi J, Dolgos J. Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis. Pathol Oncol Res. 2007;13(2): 157-60.10.1007/BF0289349317607379]Search in Google Scholar
[11. Allen CE, Li L, Petere TL, Leung HC, Yu A, Man TK. Cell-specific gene expression in Langerhans cell histiocytosis lesions reveals a distinct profile compared with epidermal Langerhans cells. J Immunol. 2010; 184(8):4557-67.10.4049/jimmunol.0902336314267520220088]Search in Google Scholar
[12. Allen CE, McClain KL. Interleukin-17A is not expressed by CD207(+) cells in Langerhans cell histiocytosis lesions. Nat Med. 2009; 15(5 ):483-5.10.1038/nm0509-483282082819424201]Search in Google Scholar
[13. Bank MI, Gudbrand C, Rengtved P, Carstensen H, Fadeel B, Henter JI et al. Immunohistochemical detection of the apoptosis-related proteins FADD, FLICE, and FLIP in Langerhans cell histiocytosis. J Pediatr Hematol Oncol. 2005;27(6):301 -6.10.1097/01.mph.0000168725.57143.5215956881]Search in Google Scholar
[14. da Costa CE, Szuhai K, van Eijk R, Hoogeboom M, Sciot R, Mertens F, et al. No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies. Genes Chromosomes Cancer. 2009;48(3):239-49.10.1002/gcc.2063419051326]Search in Google Scholar
[15. HarocheJ,CharlotteF,Amaud L, VonDeimlingA, Helias-Rodzewicz Z, Hervier B, et al. High prevalence of BRAF mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses. Blood. 2012; 120(13):2700-3.10.1182/blood-2012-05-430140]Search in Google Scholar
[16. Nelson DS, van Halteren A, Quispel WT, van den Bos C, Bovee JV, Patel B, et al. MAP2K1 and MAP3K1 mutations in langerhans cell histiocytosis. Genes Chromosomes Cancer. 2015;54(6):361 -8.10.1002/gcc.22247]Search in Google Scholar
[17. Satoh T, Smith A, Sarde A, Lu HC, Mian S, Trouillet C, et al. B-RAF mutant alleles associated with Langerhans cell histiocytosis, a granulomatous pediatric disease. PLoS ONE 2012;7(4):e33891.10.1371/journal.pone.0033891]Search in Google Scholar
[18. Cerri S, Spagnolo P, Luppi F, Richeldi L. Smoking-related interstitial lung disease. In: Cordier JF, editor. Orphan Lung Diseases: Volume 54 of European Respiratory Monograph. Plymouth: European Respiratory Society; 2011.376 p.10.1183/1025448x.10008710]Search in Google Scholar
[19. Strenger V, Urban C. Chromosomal integration of the HHV-6 genome as a possible cause of persistent HHV-6 detection in a patient with langerhans cell histiocytosis. Pathol Oncol Res. 2010; 16(1): 125-6.10.1007/s12253-009-9197-2]Search in Google Scholar
[20. Ribeiro KB, Degar B, Antoneli CB, Rollins B, Rodriguez-Galindo C. Ethnicity, race, and socioeconomic status influence incidence of Langerhans cell histiocytosis. Pediatr Blood Cancer. 2015 ;62(6);982-7.10.1002/pbc.25404]Search in Google Scholar
[21. Delobbe A, Durieu J, Duhamel A, Wallaert B, the Groupe d'Etude en Pathologie Interstitielle de la Societe de Pathologie Thoracique du Nord. Determinants of survival in pulmonary Langerhans' cell granulomatosis (histiocytosis X). EurRespirJ. 1996;9:2002-6.10.1183/09031936.96.09102002]Search in Google Scholar
[22. Watanabe R, Tatsumi K, Hashimoto S, Tamakoshi A, Kuriyama T. Clinico epidemiological features of pulmonary histiocytosis X. Intern Med. 2001;40:998-1003.10.2169/internalmedicine.40.998]Search in Google Scholar
[23. Ivanov S. [Sarcoidosis and other granulomatoses], Sofia: Nasko-1701; 2000. Bulgarian.]Search in Google Scholar
[24. Gaensler E, Carrington C. Open biopsy for chronic diffuse infiltrative lung disease: clinical, roentgenograph!c, and physiological correlations in 502 patients. Ann Thorac Suig. 1980;30:411 -26.10.1016/S0003-4975(10)61291-X]Search in Google Scholar
[25. Haupt R, Minkov M, Astigarraga I, Schafer E, Nanduri V, Jubran R, et al. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60(2): 175-84.10.1002/pbc.24367455704223109216]Search in Google Scholar
[26. Lampert F. Langerhans cell histiocytosis. Historical perspectives. Hematol Oncol Clin North Am. 1998; 12(2): 213 -9.]Search in Google Scholar
[27. Kluge G, Sorge I, Bierbach U, Hirsch W. Scapula as an uncommon site of Langerhans cell histiocytosis in an infant. Pediatr Int. 2010;52(1): 142-4.10.1111/j.1442-200X.2009.02944.x]Search in Google Scholar
[28. Friedman PJ,Liebow A A, SokoloffJ. Eosinophilic granuloma of lung. Clinical aspects of primary histiocytosis in the adult. Medicine (Baltimore). 1981;60:385-96.10.1097/00005792-198111000-00001]Search in Google Scholar
[29. Unger J, England D, Collins J. Miliary nodules, Hodgkin's disease, and eosinophilic granuloma. J Thorac Imaging. 1994;9:71-3.10.1097/00005382-199421000-00002]Search in Google Scholar
[30. Lahey ME. Prognosis in retinucloendotheliosis in children. J Pediatr. 1962;60:664-71.10.1016/S0022-3476(62)80091-2]Search in Google Scholar
[31. Arico M, Haupt R, Russotto VS, Bossi G, Scappaticci S, Danesino C. Langerhans cell histiocytosis in two generations: a new family and review of the literature. Med Pediatr Oncol. 2001;36:314-6.10.1002/1096-911X(20010201)36:2<314::AID-MPO1072>3.0.CO;2-1]Search in Google Scholar
[32. Marinova D, Titorenkov P, Slavova Y. [Pulmonary Langerhans Cell Histiocytosis]. Inspiro. 2013;4(24): 39-42. Bulgarian.]Search in Google Scholar
[33. Chaowalit N, Pellikka PA, Decker PA. Echocardiographic and clinical characteristics of pulmonary hypertension complicating pulmonary Langerhans cell histiocytosis. Mayo Clin Proc. 2004;79:1269-75.10.4065/79.10.1269]Search in Google Scholar
[34. Crausman RS, Jennings CA, Tuder RM, Ackerson LM, Irvin CG, King TE Jr. Pulmonary histiocytosis X: pulmonary function and exercise pathophysiology. Am J Respir Crit Care Med. 1996;153:426-35.10.1164/ajrccm.153.1.8542154]Search in Google Scholar
[35. Fridlender ZG, Glazer M, Amir G, Berkman N. Obstructing tracheal pulmonary Langerhans cell histiocytosis. Chest. 2005; 128:1057-8.10.1378/chest.128.2.1057]Search in Google Scholar
[36. Sundar KM, Gosselin MV, Chung HL, Cahill BC. Pulmonary Langerhans cell histiocytosis: emerging concepts in pathobiology, radiology, and clinical evolution of disease. Chest. 2003;123:1673-83.10.1378/chest.123.5.1673]Search in Google Scholar
[37. Vassallo R, Ryu JH, Colby TV, Hartman T,Limper AH. Pulmonary Langerhans'-cell histiocytosis. N Engl J Med. 2000;342:1969-78.10.1056/NEJM200006293422607]Search in Google Scholar
[38. Simko SJ, McClain KL, Allen CE. Up-front therapy for LCH: is it time to test an alternative to vinblastine/prednisone? Br J Haematol. 2015; 169(2):299-301.10.1111/bjh.13208]Search in Google Scholar
[39. Veys PA, Nanduri V, Baker KS, He W, Bandini G, Biondi A, et al. Haematopoietic stem cell transplantation for refractory Langerhans cell histiocytosis: outcome by intensity of conditioning. BrJ Haematol. 2015; 169(5):711-8.10.1111/bjh.13347]Search in Google Scholar
[40. Arico M, Astigarraga I, Braier J, Donadieu J, Gadner H, Glogova E, et al. Lack of bone lesions at diagnosis is associated with inferior outcome in multisystem langerhans cell histiocytosis of childhood. Br J Haematol. 2015; 169(2):241 -8.10.1111/bjh.13271]Search in Google Scholar
[41. Egeler RM, Neglia JP, Puccetti DM, Brennan CA, Nesbit ME. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71:865-73.10.1002/1097-0142(19930201)71:3<865::AID-CNCR2820710334>3.0.CO;2-0]Search in Google Scholar
[42. Vassallo R, Ryu JH, Schroeder DR, Decker PA, Limper AH. Clinical outcomes of pulmonary Langerhans'-cell histiocytosis in adults. N Engl J Med. 2002;346:484-90.10.1056/NEJMoa012087]Search in Google Scholar
[43. Thomeer M, Demedts M, Vandeurzen K. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders. Acta Clin Belg. 2001;56:163-72. 10.1179/acb.2001.026]Search in Google Scholar